Connection

DAVID G MENTER to Sulindac

This is a "connection" page, showing publications DAVID G MENTER has written about Sulindac.
Connection Strength

0.225
  1. Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development. BMC Cancer. 2020 Sep 10; 20(1):871.
    View in: PubMed
    Score: 0.182
  2. Effect of cyclooxygenase inhibitors in the adhesion of tumor cells to endothelial cells. Crit Rev Biomed Eng. 2000; 28(1-2):193-4.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.